// App-Quantinova.ai

426 : The Incidence of Venous Thromboembolism (VTE) in 892 Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients ( A single institution study comparison of VTE incidence with sirolimus versus non-sirolimus-based GVHD prophylaxis)

Researchers

Presenter

  • John Mathews

Principal Investigators

  • Binglin Yue

  • Michael L. Nieder

  • Frederick L Locke

  • Jongphil Kim

  • Claudio Anasetti

  • Hugo Fernandez

  • Josephine Emole

  • Taiga Nishihori

  • Vikas Bhushan

Medical Centers

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

  • Texas Oncology, Dallas, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Venous thrombosis

  • Solid malignancies

  • Graft-versus-host disease

Biomarkers

  • N/A

Drug/Treatment

  • fludarabine tablet

  • Melphalan

  • Rapacan

  • Busulfan

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved